Glanbia PLC

Glanbia PLC

22.48
EUR
-0.18
(-0.79%)
5.89BMarket Cap
Mar 03Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
15.07
11.75
10.17
7.95
9.71
14.09
16.24
19.21
16.38
21.55
20.35
14.74
15.75
- -
Basic EPS, GAAP
0.95
0.68
0.67
0.75
1.34
1.04
0.75
0.72
0.65
0.98
1.29
0.63
0.73
- -
Free Cash Flow per Basic Share
0.01
0.28
0.56
0.83
0.08
0.94
0.57
1.07
0.68
0.88
1.33
1.37
1.13
- -
Dividend per Share
0.18
0.14
0.12
0.13
0.17
0.34
0.31
0.39
0.31
0.32
0.36
0.4
0.47
- -
Book Value per Share
4.01
3.68
3.86
4.32
5.6
7.04
7.11
8.12
6.83
7.33
8.12
8.08
7.95
7.85
Tangible Book Value per Share
1.14
0.62
0.38
0.89
1.71
1.26
1.49
1.86
1.41
1.61
2.27
1.81
1.62
1.55
Basic Weighted Avg Shares
295
295
295
295
295
295
295
295
290
276
267
261
251
244
Sales/Revenue/Turnover
4,442
3,467
3,003
2,347
2,864
4,159
4,794
5,671
4,752
5,944
5,425
3,840
3,946
- -
Operating Margin (%)
7.03
7.3
7.7
9.93
9.25
7.54
4.61
3.11
3.79
3.98
7.18
6.09
6.95
- -
Depreciation Expense
90
75
80
95
135
117
135
185
144
150
149
156
149
- -
Net Income, GAAP
280
200
198
223
395
307
223
213
189
271
344
165
183
- -
Effective Tax Rate (%)
14.21
15.2
15.9
16.47
- -
12.29
9.49
7.86
10.76
11.42
11.39
20.82
12.38
- -
Profit Margin (%)
6.31
5.76
6.61
9.49
13.8
7.38
4.65
3.76
3.98
4.57
6.35
4.29
4.64
- -
Working Capital
497
459
413
382
482
592
269
213
613
461
603
433
434
578
LT Debt
824
847
815
656
599
987
636
820
909
786
643
637
730
922
Total Equity
1,200
1,099
1,151
1,291
1,658
2,085
2,105
2,391
1,971
1,993
2,133
2,073
1,927
1,897
Return on Invested Capital (%)
13.87
9.99
9.76
9.56
- -
9.89
6.11
4.5
4.69
6.6
11.22
6.04
7.63
- -
Return on Capital (%)
15.95
11.16
10.9
12.12
- -
12.13
8.15
7.27
6.26
9.48
12.09
6.33
6.87
- -
Return on Common Equity (%)
26.4
17.58
17.79
18.41
26.92
16.41
10.64
9.49
8.69
13.76
16.73
7.83
9.16
- -

Capital Structure

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
192
396
286
LT Borrowings
754
642
841
LT Finance Leases
91
88
81
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
253
242
242
Market Capitalization
3,712
4,108
6,732

Working Capital

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
1,499
1,652
1,663
Cash, Cash Equivalents & STI
276
491
376
Accounts Receivable, Net
488
381
510
Inventories
702
663
752
Total Current Liabilities
898
1,219
1,086
Payables & Accruals
- -
- -
- -
ST Debt
192
396
286
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.17%
-3.85%
-7.02%
Free Cash Flow
116.63%
2.36%
-20.33%
Net Income, GAAP
5.39%
3.64%
11.29%
Sales/Revenue/Turnover
5.27%
-5.26%
2.78%
Total Cash Common Dividend
15.94%
1.06%
12.84%

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3,840
2025
- -
- -
3,946
2026
- -
- -
- -

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.63
2025
- -
- -
0.73
2026
- -
- -
- -

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.4
2025
- -
- -
0.47
2026
- -
- -
- -

Company Description

CEO
Hugh McGuire
Full Time Employees
5,800
Sector
Consumer non-durables
Industry
Food: meat/fish/dairy
Address
Leggetsrath Business Park Kilkenny KK Ireland R95 YTD5
IPO Date
Mar 1, 1988
Business
Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland, and founded in 1997 through the merger of Avonmore and Waterford cooperatives. The company operates primarily through three divisions--Glanbia Nutritionals, Glanbia Performance Nutrition, and Joint Ventures--focusing on dairy-based nutritional ingredients and consumer sports nutrition products; its core offerings include whey protein concentrates and isolates, nutritional premixes, flavor systems, custom dairy blends, cheese and non-dairy proteins, vitamin and mineral premixes, as well as branded performance nutrition products such as Optimum Nutrition protein powders, Isopure zero-carb proteins, thinkThin and Quest protein bars, SlimFast meal replacements, and BSN supplements sold in powder, ready-to-drink, and bar formats. Glanbia Nutritionals supplies functional ingredients to food, beverage, and pharmaceutical manufacturers worldwide, while Glanbia Performance Nutrition targets athletes, health-conscious consumers, and lifestyle markets via retail, e-commerce, gyms, and foodservice channels; the company serves over 130 countries with major operations in North America, Europe, Asia-Pacific, Latin America, and the Middle East, including manufacturing facilities in the US, Ireland, UK, Germany, and China. In recent developments, Glanbia completed the 2024 acquisition of Flavor Producers LLC for an initial $300 million plus up to $55 million in deferred consideration to bolster its natural and organic flavors platform within Glanbia Nutritionals; the company also announced in late 2024 a restructuring of its Nutritionals business effective 2025 into separate Health and Nutrition and Dairy Nutrition segments, alongside ongoing share buyback programs totaling €150 million including a new €50 million tranche starting early 2025. Glanbia continues to divest non-core assets, such as its 2022 sale of the 40% stake in Glanbia Ireland (now Tirlán), to sharpen focus on global nutrition solutions amid strong revenue growth exceeding €3.5 billion annually from high-demand health and wellness categories.

Company News

  • Longleaf Partners Global Fund Q3 2026 Portfolio Review

  • Glanbia plc (OTCMKTS:GLAPF) Sees Large Increase in Short Interest

  • Glanbia (OTCMKTS:GLAPF) Share Price Crosses Below 200-Day Moving Average – Time to Sell?

  • Glanbia (OTCMKTS:GLAPF) Share Price Crosses Above 200 Day Moving Average – Here’s Why

  • Glanbia hikes profit forecast as weight-loss drugs boost demand for protein products